Medical News


Clinical Trials Present Better Alternatives for Dialysis Patients

But an unhealthy kidney costs more-about $16 billion more, as per Prabir Roy-Chaudhury, MD, PhD, associate professor in the division of nephrology and high blood pressure at the University of Cincinnati (UC). “It costs about $17 billion a year to care for patients with end-stage kidney disease,” he said……..

Original post by Health news from medicineworld.org

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists



Related Articles
  • Americans pay the most for prescription drugs
  • Nonsmall cell lung cancer: chemotherapy before surgery
  • Vitamin E trials ‘fatally flawed’
  • Alzheimer’s drug begins clinical trials
  • Lasik America Signs Letter of Intent to Acquire Interest in Five Dialysis Centers, Expanding Current Medical Technology Portfolio
  • No comments yet. Be the first.

    Leave a reply

    Clinical Trials Present Better Alternatives for Dialysis Patients

    But an unhealthy kidney costs more-about $16 billion more, as per Prabir Roy-Chaudhury, MD, PhD, associate professor in the division of nephrology and high blood pressure at the University of Cincinnati (UC). “It costs about $17 billion a year to care for patients with end-stage kidney disease,” he said……..

    Original post by Health news from medicineworld.org

    Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
    • Digg
    • del.icio.us
    • Netvouz
    • DZone
    • ThisNext
    • MisterWong
    • Wists



    Related Articles
  • Americans pay the most for prescription drugs
  • Nonsmall cell lung cancer: chemotherapy before surgery
  • Vitamin E trials ‘fatally flawed’
  • Alzheimer’s drug begins clinical trials
  • Lasik America Signs Letter of Intent to Acquire Interest in Five Dialysis Centers, Expanding Current Medical Technology Portfolio
  • No comments yet. Be the first.

    Leave a reply